Creative Biolabs is strengthening its lipid-based delivery portfolio with enhanced lipid nanoparticle (LNP) and liposome engineering capabilities designed to support the growing demand for RNA ...
Through predictive modelling, AI supports target identification, prediction of physicochemical properties and formulation strategy selection.
Formulation complexity, especially in small molecule drugs, has been getting more attention as capabilities continue to ...
Research-driven company cites two peer-reviewed studies as its standardized wellness formulations prepare to launch on ...
Intravacc offers four complementary vaccine development platforms: bacterial vaccines, viral vaccines, conjugate vaccines, and E.coli expressed ...
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphereâ„¢ technology designed to optimize ...
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging ...
The completed 300g scale-up batch forms part of Dalton Pharma Services' Process Optimization and Intermediate Scale-Up Program and follows the successful completion of process development activities ...
Pharmaceutical engineering is a powerful career pathway for students who want to turn scientific knowledge into medicines that make a real difference to patients’ lives.
VANCOUVER, BC / ACCESS Newswire / June 23, 2026 / Onco-Innovations Limited (NEO:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has entered into a ...
Linuo Pharmaceutical Packaging Co., Ltd. (Linuo Pharmaceutical Packaging) was invited to speak at the Third Global Expansion ...
PALO ALTO, Calif.--(BUSINESS WIRE)--GEn1E Lifesciences Inc., a Phase 2 clinical-stage biotechnology company advancing AI-driven novel precision medicines for immunology, inflammation, and rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results